Acinetobacter Pneumonia Therapeutics Industry: Emerging Therapeutic Approaches for Treating Acinetobacter Pneumonia Infections Worldwide
Burden of Acinetobacter Pneumonia Therapeutics Industry Acinetobacter baumannii is a gram-negative bacterium that is an emerging cause of hospital-acquired and ventilator-associated pneumonia worldwide. It has …